Dr Agius is the founder and medical director of The Pain Clinic, a team of professionals that offer holistic management of chronic pain and other illnesses that haven't responded to conventional medication. Dr Agius has been exploring various options to help his patients and lobbied hard to make medical cannabis accessible in Malta. He is now one of Malta's top medical cannabis prescribers.

Stefan Broselid is an accomplished researcher with a Ph.D. in Molecular Pharmacology and extensive experience in preclinical drug development targeting G Protein-Coupled Receptors (GPCRs). He is currently serving as a Medical Advisor/MSL for Aureum Life, a leading cannabis investment company based in Sweden. In this role, Stefan provides valuable insight and expertise on the medical benefits of cannabis and its potential to treat a wide range of conditions. He also serves as a key liaison between Aureum Life and its subsidiary cannabis pain clinics, where he plays an instrumental role in shaping the companies’ overall medical- and research strategies. Stefan also works with educating physicians and other healthcare professionals about the science and unique polypharmacology pertaining to medical cannabis.

Dr. Sandra Carrillo is a renowned global medical cannabinoid specialist based in Colombia, the epicenter of cannabis history and culture. She is an ardent campaigner for physician education on cannabinoid science as well as patient access to medicinal cannabis, propelling the evolution of healthcare worldwide.
Sandra Carrillo MD LinkedIn Profile

Dr. Luciana Cobo graduated from the Medical Academy in 1999. While her specialties are Medical Clinic and Forensic Medicine, from the outset of her practice, she has embraced integrative medicine, addressing her patients' physical, psychological and social aspects of care. Since 2019, she has been studying the endocannabinoid system and treating patients with an integrative approach using medical cannabis. In 2021, she earned a Medical Cannabis Expertise certification from the Latin American Society of Phytomedicine and, in 2022, received additional certification from the Multidisciplinary Center on Cannabinoid Research at the Hebrew University of Jerusalem. Dr. Cobo maintains ongoing collaborations in research and patient care with colleagues worldwide, including USA, Spain, Chile, the Australian Association of Psychologists Psychedelic Assisted Therapy, professionals from Israel, Colombia, Paraguay, Peru, and more. A strong advocate of Hippocrates' philosophy—"It is more important to know the person who has the disease than to know the disease the person has"—Luciana believes in personalized, holistic care. She views Cannabis sativa as a key tool in empowering patients to manage their own health.

Dr Winsome Christie, a clinical pharmacist and Natural Health Consultant, has over 30 years’ experience in pharmaceutical and alternative medicine. Dr Christie is a recognised authority in the field of medicinal cannabis, having developed and delivered training programs and certificate courses on the subject for healthcare professionals, including pharmacists and students. Her mission is to educate patients, professionals, and industry, advancing integrative, patient-centred care.

Dr Rob Greig FRCEM is an Emergency Medicine Consultant based in Jersey, Channel Islands. He became a CBMP prescriber in 2021 having previously been a sceptic of this field. He works at Medicann®️ Jersey, for five sessions a week. Rob is published in topics related to emergency medicine, lectured in pharmacology and spoken at conferences. Recently he has started delivering webinars on medicinal cannabis treatment. Having a generalist background, as befits his training & specialty, he treats a variety of pathology groups, working closely within a structured MDT supported environment.

Clare graduated from Liverpool, UK in 1997 and has lived and worked in New Zealand for the past 23 years. Though her work focus has been emergency medicine, her major interests are in nutritional and plant medicine. Her mission is to destigmatise medicinal cannabis use in New Zealand and to develop educational tools and resources for patients, health professionals and industry.

Tina Horsted has over 30 years of experience in patient care. Ten years as a general nurse and nurse anesthetist, and twenty years as a physician specializing in anesthesiology, intensive care medicine and pain management. Tina Horsted is trained and certified by SSAI (Scandinavian Society of Anesthesiology and Intensive Care Medicine) in pain management. Tina has worked in hospitals in Denmark and as a senior physician in both Sweden and Norway. She has taught nurses, physicians, heads of medical departments and lectured at various medical courses and congresses in Denmark and abroad. In 2018, Tina Horsted published the book Medical Cannabis – Quality of Life and Pain Relief with Cannabis Medicine from Gyldendal l publishing house, with a foreword by then Danish Minister of Health Ellen Trane Nørby. Tina Horsted has served as supervisor of scientific research and medical education, running quality assurance projects, and continuously publishing scientific articles.

Dr. Kwinter completed his Bachelor of Science in Molecular Biology and Biochemistry at Simon Fraser University where he published research about axonal transport of organelles. He then decided to pursue medicine and graduated from the University of Kentucky College of Medicine and completed post-graduate training in Family Medicine at Memorial University of Newfoundland. He practiced rural family and emergency medicine for 10 years before relocating to Grand Cayman. He is the Clinical Chief of Concierge Medicine and Primary Care at Cayman Medical Ltd. With his perspective as a clinician and former molecular biologist, he enjoys keeping up to date with cannabis research. He believes that medical cannabis is still in its infancy and aims to help his patients benefit from new discoveries and new medical cannabis products.

Adam is a seasoned executive with experience in academic research, business and Cannabis operations. Over the past seven years Adam served as the Chief Scientific Officer at Holistic Industries, a large multi-state vertically integrated US Cannabis operator. During his tenure, he built the extraction and manufacturing programs which he scaled from one facility into nine. Adam also built the science program where he developed extraction and isolation techniques to create and launch six product lines, including patented formulations currently in clinical trials. Prior to his work in the cannabis industry, Adam spent ten years in academic research, focusing on plant biology and cancer pharmacology. He earned a Ph.D. in plant chemistry and continued his research in cancer pharmacology at Cornell Medical College, which resulted in more than 10 peer-reviewed publications and a patent. Adam's entrepreneurial spirit also led him to build an internationally-distributed food science business, which was successfully acquired after a four-year startup. Adam is now focused on applying his background in scientific research, product development and operations to support emerging startups to become industry leaders.

Dr Lewis is a Pediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy. He is the founder & director of the Neurology Centre of Toronto (NCT). He is an Assistant Professor with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto.

Dr. Dedi Meiri heads the Laboratory of Cancer Biology and Cannabinoid Research in the Technion Faculty of Biology. Dr. Meiri’s lab, the largest of its kind in academia with 44 researchers, investigates the therapeutic potential of cannabinoids, the naturally-occurring chemicals found in the cannabis plant. Researchers work on a variety of projects in the lab with its main focus on how cannabinoids affect various types of cancer, epilepsy, and diabetes. Dr. Meiri aims to understand the cannabis plant thoroughly enough so that a doctor can prescribe the right treatment at the right dosage for a particular patient. To that end, he collaborates with cannabis growers, clinicians, major manufacturers, and distributors of medical cannabis to identify almost every strain of marijuana grown in Israel, matching them to the diseases they affect. He has launched the Database Project, which exhaustively profiles compounds given to Israel’s 60,000 medical marijuana patients. Dr. Meiri also helps Israel’s Ministry of Health advance its understanding of cannabis usage.

Sangeeta Nathoo is a pharmacist with an MBA and clinical cannabinoid training, bringing a multifaceted perspective to the healthcare industry. She serves on Mauritius's Government-appointed Scientific and Technical Committee and Implementation Committee on Medicinal Cannabis, driving legislative changes and implementation for medical cannabis in Mauritius. She served as a part-time lecturer at the University of Zimbabwe for over 6 years and is pursuing her Master’s in Cannabis Science and Therapeutics at the University of Maryland. Her experience spans retail, wholesale, manufacturing, and product and business development across Zimbabwe, Mauritius, and southern African countries navigating pharmaceutical regulations and business practices in diverse environments. She works to increase access to cannabis-based medicine through consulting, research, education, and product availability.

Dr Angeliki Papastefanou is a Psychiatrist and has been prescribing CBPM for the last 5 years. Dr Angeliki has gained deep insight into the medicinal effects of cannabis over the years of prescribing the medicine to thousands of patients and has become a passionate supporter of it. The doctor reports significant positive results in her patients and minimal side effects with medical cannabis treatment and believes that CBPM would be the future asset to many national health systems that struggle with expensive and ineffective medicines. Dr Angeliki’s mission is to spread the use of CBPM for mental health patients and to alter collective consciousness that has been mould within the limits of ‘stigma’ as it has often been associated with illegality. Dr Angeliki has worked in Greece, U.K. and the Republic of Ireland and has developed a keen interest in the treatment of adult ADHD with CBPM along with other controlled drugs. She strives to achieve wider access of CBPM to patients and services and is dedicated to collaborating with other medical professionals and law enforcement agencies in the U.K. and abroad. The goal is to educate patients, clinicians and governments about CBPM, to treat disorders with this highly cost-effective medicines and overall to improve mental and physical suffering worldwide.

Doctor Jarosław Uziałło graduated from the Medical Academy in 1996. From the beginning of his medical practice, he participated in the diagnosis and treatment of various diseases. While working as an intern, he assisted with operations at the Oncology Center, with which he was involved for many years. The motto of the doctor "Medicine is one" made him deal with all kinds of diseases, both in children and adults and the elderly.